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Abstract: 
Protein Tyrosine Phosphatases (PTPs) that function as negative regulators of the insulin signaling cascade have been identified as 
novel targets for the therapeutic enhancement of insulin action in insulin resistant disease states. Reducing Protein Tyrosine 
Phosphatase1B (PTP1B) abundance not only enhances insulin sensitivity and improves glucose metabolism but also protects 
against obesity induced by high fat feeding. PTP1B inhibitors such as Formylchromone derivatives, 1, 2-Naphthoquinone 
derivatives and Oxalyl aryl amino benzoic derivatives may eventually find an important clinical role as insulin sensitizers in the 
management of Type-II Diabetes and metabolic syndrome. We have carried out docking of modified oxalyl aryl amino benzoic 
acid derivatives into three dimensional structure of PTP1B using BioMed CAChe 6.1. These compounds exhibit good selectivity 
for PTP1B over most of phosphatases in selectivity panel such as SHP-2, LAR, CD45 and TCPTP found in literature. This series 
of compounds identified the amino acid residues such as Gly220 and Arg221 are important for achieving specificity via H-
bonding interactions. Lipophilic side chain of methionine in modified oxalyl aryl amino benzoic acid derivative [1b (a2, b2, c1, d)] 
lies in closer vicinity of hydrophobic region of protein consisted of Meth258 and Phe52 in comparison to active ligand. Docking 
Score in [1b (a2, b2, c1, d)] is -131.740Kcal/mol much better than active ligand score -98.584Kcal/mol. This information can be 
exploited to design PTP1B specific inhibitors. 
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Background: 
Type-II Diabetes mellitus is the most common form of 
diabetes. In this case, patients can still produce insulin, but 
they do not produce enough or their bodies can't use it 
properly. At present, there are about 125 million people 
affected by the disease globally. It has been projected by 
the year 2010; the no. of persons with diabetes will double. 
[1] Reversible protein phosphorylation is the predominant 
strategy used to control the activity of proteins in 
eukaryotic cells. Approximately 30% of 10,000 proteins in 
a typical mammalian cell are thought to be phosphorylated. 
[2] Many cellular functions could be artificially 
manipulated if one could exogenously control the activity 
of protein kinases and phosphatases. [3]  This has led to 
intense interest in identifying small molecules capable of 
inhibiting action of specific kinases. [4] or phosphatases. [5, 
6] Major goal of new therapies for Type-II Diabetes is to 
potentiate action of insulin. One of key proteins involved in 
insulin signaling is insulin receptor. When insulin binds to 
its receptor, changes in intracellular confirmation of 
receptor result in o-phosphorylation of specific tyrosine 
residues. [7] This serves as first step in insulin signaling 
and it is followed by a cascade of intracellular events that 
mediate the physiological effects of insulin. [8]  There is 
compelling evidence that protein tyrosine phosphatase 1B 
is primarily responsible for dephosphorylation of insulin 
receptor and therefore acts to downregulate insulin signaling. 
[9-13] A PTP1B inhibitor would be expected to increase the 
half life of phosphorylated insulin receptor and enhance the 
effects of insulin. The development of PTP1B inhibitors began 
in early 1990 and continues today. [14, 15] Formylchromone 
derivatives  [16], 1, 2-Naphthoquinone derivatives [17] and 
Oxalyl aryl amino benzoic acid derivatives [18] have been 
identified as potent inhibitors for PTP1B. In an effort to 
develop a small, potent and selective PTP1B inhibitor, we used 
iterative structure based drug design to identify and optimize a 
lead compound.  
 
Methodology:  
Crystal structure of PTP1B 
The crystal structure of PTP1B (PDB-ID: 1NZ7) was retrieved 
from protein data bank (http://www.rcsb.org) and its 
coordinates were selected for docking studies by BioMed 
CAChe 6.1. This crystal structure of PTP1B contains 
2563atoms. Before docking H-atoms were added to protein for 
correct ionization and tautomeric states of amino acid residues 
such as Asp, Ser, Glu, Arg, His and also bond types were 
corrected for HET groups.Bioinformation by Biomedical Informatics Publishing Group                                     open access 
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Figure 1: (a) active compound; (b) modified active compound. 
 
Active site analysis 
The active site was analyzed by selecting neighbors within 
3Å around ligand. The active site contains Arg24, Ser28, 
Tyr46, Asp48, Val49, lys120. Ser216, Ala217, Gly218, 
Meth258, Gly259, Gln262, Thr263 and Gln266. 
 
Selection of docking molecules 
A set of 63 inhibitors as shown in Figure 1b were designed 
in Chem office software from most active oxalyl aryl 
amino benzoic acid derivative found from literature [18] 
whose structure is shown in Figure 1a. The active molecule 
was modified from position a, b, c and d as shown in 
Figure 1b.                         
 
Molecular modeling 
Phosphatase1B inhibitors were built and energy minimized 
on Biomed CAChe. For calculating energy BioMed 
CAChe provides classical mechanics, quantum mechanics 
and includes solvent effects of water by using COSMO 
(Conductor-like screening Model, which approximates the 
dielectric screening energy of a solvent by the method of 
image charges). The geometry optimization was carried out 
for each modified molecule by solving Schrodinger 
equation using the MOPAC6 (Molecular Orbital Package, 
which contains a method for modeling the effect of highly 
polar solvents) and semi empirical AM1 Hamiltonian.  
 
Docking by superposition 
The fastest and easiest method for docking a ligand into 
active site is to superimpose the ligand on to a bound 
ligand already in the active site and then delete the bound 
ligand. The modified ligand was superimposed on already 
docked ligand (active molecule) in crystal structure of 
PTP1B and then already docked ligand was removed and 
then H-bonds were calculated among modified ligand and 
PTP1B. 
 
BioMed CAChe docking score 
Docking score was carried out in project leader of BioMed 
CAChe in which active site of PTP1B was fixed but ligand was 
flexible. Cache docking score performs force fields which 
includes terms as bond stretching, angle bending, torsional, and 
nonbonded interactions such as Vander Waals and Hydrogen 
bond interactions. The molecule based scoring function is made 
up of four components  1. Protein-ligand H-bond energy 
(external H-bond). 2. Protein-ligand Vander Waals energy 
(external vdw) 3. Ligand internal Vander waals energy (internal 
vdw)  4. Ligand intramolecular H-bond energy (internal H-
bond). Docking Score = S (hb_ext) + S (vdw_ext) + S (hb_int) 
+ S (vdw_int) 
 
Results and discussion:  
The docking of modified oxalyl aryl amino benzoic acid 
derivatives into active site of PTP1B was carried out using 
Cache 6.1. The final docking score in Kcal/mol for each 
docking experiment was calculated. The docking evaluations 
were made on basis of H-bond and docking score. The 
molecules having improved docking score and H-bonding 
interactions are given below: 
 
CACheScore fitness function for active molecule  
From docking of active molecule (Figure 1a) into active site of 
PTP1B, we observed five H-bonds with protein amino acid 
residues that are Gly220, Ala217, Asp48, Gln262 and Arg221, 
as indicated in Table 1a (supplementary material). Active 
molecule entered into hydrophobic region of protein comprising 
amino acid residues indicated in Table 2 (supplementary 
material). The docking score was found to be -98.584Kcal/mol.
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Figure 2: Cache score based interactions of molecule [1b (a2, b2, c1, d)] docked into active site of PTP1B 
 
CACheScore fitness function for modified active 
molecules 
Three H-bonds were observed with protein amino acid 
residue Arg24 only, as indicated in Table 1a 
(supplementary material) when [1b (a2, b1, c3, d)] molecule 
was docked into active site of PTP1B. The docking score 
was found to be -130.261Kcal/mol. Modified inhibitor 
entered into hydrophobic region of protein comprising 
amino acid residues indicated in Table 2 (supplementary 
material). The best RMSD was found to be 0.8523. 
 
Four H-bonds were observed with protein amino acid 
residues that are Ala217, Arg221, Gly220 and Arg24 as 
indicated in Table 1a (supplementary material) when [1b(a3, 
b2, c2, d)] molecule was docked into active site of PTP1B.  
The docking score was found to be -130.596Kcal/mol. 
Modified inhibitor entered into hydrophobic region of 
protein comprising amino acid residues indicated in Table 
2 (supplementary material). The best RMSD was found to 
be 0.7418. 
 
Seven H-bonds were observed with protein amino acid 
residues that are Ala217, Arg221, Gly220, Gly218 and 
Arg24 as indicated in Figure 2 and Table 1a 
(supplementary material) when [1b(a2, b2, c1, d)] molecule 
was docked into active site of PTP1B. 
 
The docking score was found to be -131.740Kcal/mol. 
Modified inhibitor entered into hydrophobic region of 
protein comprising amino acid residues indicated in Table 
2 (supplementary material). The best RMSD was found to 
be 1.0956. 
 
Two H-bonds were observed with protein amino acid 
residue Ala217 only as indicated in Table 1b 
(supplementary material) when [1b (a3, b2, c1, d)] molecule 
was docked into active site of PTP1B, The docking score 
was found to be -122.297Kcal/mol. Modified inhibitor entered 
into hydrophobic region of protein comprising amino acid 
residues indicated in Table 2 (supplementary material). The best 
RMSD was found to be 0.5276.  
 
Four H-bonds were observed with protein amino acid residues 
that are Ala217, Ile219, Gly220 and Gln262 as indicated in 
Table 1b (supplementary material) when [1b(a4, b2, c3, d)] 
molecule was docked into active site of PTP1B. The docking 
score was found to be -126.602Kcal/mol. Modified inhibitor 
entered into hydrophobic region of protein comprising amino 
acid residues indicated in Table 2 (supplementary material). 
The best RMSD was found to be 0.6264.  
 
Three H-bonds were observed with protein amino acid residues 
that are Gly220, Ile219 and Asp48 as indicated in Table 1b 
(supplementary material) when [1b(a2, b3, c2, d)] molecule was 
docked into active site of PTP1B. The docking score was found 
to be -121.306Kcal/mol. Modified inhibitor entered into 
hydrophobic region of protein comprising amino acid residues 
indicated in Table 2 (supplementary material). The best RMSD 
was found to be 0.7942. 
 
In active molecule five H-bonds have been observed whereas in 
modified molecule i.e. [1b (a2, b2, c1 d)] seven H-bonds have 
been observed and hydrophobic region has also expanded in 
modified molecule comprising amino acid residues such as 
Asp29, Gly259, Arg254, Cys226, Arg79, Glu76, Phe52, 
Met253 and Val253.But active molecule contains only three 
amino acid residues such as Arg24, Arg254 and Arg257 in 
hydrophobic region. Hence it has been observed modified 
ligand leads to stronger interaction with PTP1B than active 
molecule found from literature. Further, from our docking 
studies, it has been shown that the diamides of alanine linker 
forms H-bond with Asp48 in active ligand but not in [1b (a2, b2, 
c1, d)]. WPD loop remains open in both active ligand and [1b (a2, 
b2, c1,  d)]. Oxamic acid group in [1b (a2, b2, c1,  d)] shows Bioinformation by Biomedical Informatics Publishing Group                                     open access 
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stronger interactions with Ala217, Arg221, Gly220 and 
Gly218 in comparison to active ligand which shows 
interaction only with Gly220 and Ala217. The carboxylic 
acid of methonine in [1b (a2, b2, c1, d)] interacts with Arg24 
but not in active ligand. Lipophilic side chain of 
methionine in [1b (a2, b2, c1, d)] lies in closer vicinity of 
hydrophobic region of protein consisted of Meth258 and 
Phe52 in comparison to active ligand. Docking Score in 
[1b (a2, b2, c1, d)] is -131.740Kcal/mol which is much better 
than active ligand score -98.584Kcal/mol.  
 
Conclusion: 
A detailed docking analysis of modified oxalyl aryl amino 
benzoic acid derivatives into active site of PTP1B has been 
studied in the present work, to identify the inhibitor 
binding position and affinity to PTP1B using BioMed 
CAChe 6.1. On the basis of improved H-bonding and 
docking score than the active compound found in literature 
it has been concluded that modified oxalyl aryl amino 
benzoic acid derivative [1b(a2, b2, c1, d)]  molecule can 
proved to be better inhibitor than the active ligand found in 
literature. 
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Table 1a: List of hydrogen bonding interactions between modified inhibitors and PTP1B 
Molecule                                                                                   Cache Score 
Mol                          No. of H                     Protein                         Ligand               H bond              
name                        bonds                   residue atom                      atom                distance 
                                                                                                                                      A
o
________________________________________________________________________                                                                                                 
Active                          
Ligand                           5                         Gly220                          2304 (H)             1.684 
                                                                   (NH)  
                                                                  Ala217                          2302 (O)             1.649 
                                                                    (NH) 
                                                                  Asp48                           2585 (O)             1.930 
                                                                    (NH) 
                                                                  Gln262                          2339 (O)            2.017 
                                                                    (NH) 
                                                                  Arg221                          2315 (O)            1.908 
                                                                    (NH) 
 
 
[1b(a2,b1, c3, d)]                3                         Arg24                           5383 (H)            1.990 
a2=CH4                                                       (NH) 
b1=(CH2)2                                                  Arg24                            5357 (O)            1.926 
c3=                                                             (NH)    
     d=-CO-                                                    Arg221                         5330 (O)            2.160 
                                                                   (NH) 
 
 
[1b(a3, b2, c2 , d)]               4                          Ala217                          5317 (O)           1.364 
a3=CH3CH3                                                (NH) 
b2=(CH2)3                                                   Arg221                          5330 (O)           2.162 
c2    =                                                          (NH) 
 d=-CO-                                                      Gly220                          5319 (O)           2.193 
                                                                   (NH) 
                                                                    Arg24                           5384 (O)           2.125 
                                                                   (NH) 
 
 
[1b(a2, b2, c1,d)]               7                          Ala217                          5317 (O)            2.119   
a2=CH4                                                        (NH) 
b2=(CH2)3                                                    Arg221                         5321 (O)            1.094 
c1=                                                               (NH) 
d=-CO-                                                        Gly220                          5321 (O)            2.106 
                                                                    (NH) 
                                                                    Gly220                           5319 (O)           2.067 
                                                                    (NH) 
                                                                    Gly218                          5319 (O)            1.461 
                                                                    (NH) 
                                                                    Gly218                          5317 (O)            1.144 
                                                                    (NH) 
                                                                    Arg24                            5359 (O)            2.171 
                                                                    (NH) 
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Table 1b: List of hydrogen bonding interactions between modified inhibitors and PTP1B 
Molecule                                                                                           Cache Score                                       
Mol                                             No. of H                     Protein                              Ligand               H bond              
name                                            bonds                   residue atom                            atom                distance 
                                                                                                                                      A
o
________________________________________________________________________________________________                                                 
[1b(a3, b2 ,c1, d)]                               2                            Ala217                              5319 (O)            2.094 
a3=CH3CH3                                                                    (NH) 
b2=(CH2)3                                                                     Ala217                               5317 (O)            2.109 
c1=                                                                                  (NH) 
d=-CO- 
 
 
 
[1b(a4, b2, c3, d)]                                4                             Ala217                             5317 (O)           1.323 
a4=CH3CH2CH3                                                              (NH) 
b2=CH3CH3                                                                     Ile219                              5319 (O)           2.178 
c3=                                                                                   (NH) 
d=-CO-                                                                           Gly220                             5319 (O)           1.639 
                                                                                         (NH)     
                                                                                        Gln262                            5354 (O)           1.834 
                                                                                         (NH)    
                                                             
[1b(a2, b3, c2, d)]                                3                             Gly220                            5319 (O)           1.119 
a2=CH3                                                                             (NH) 
b3= (CH2)4                                                                       Ile219                              5319 (O)           1.978 
OH
c2=                                                                                    (NH)    
   d=-CO-                                                                           Asp48                              5378 (H)           1.857 
                                                                                           (CO) 
 
_______________________________________________________________________________________________                                                   
 
Table 2: List of amino acid residues contributing to the hydrophobic pocket in docking of modified inhibitors into PTP1B 
Modified inhibitor                                                     Hydrophobic pocket of PTP1B 
Active Ligand                                                                Arg 254, Arg24 and arg257 
[1b(a2, b1, c3, d)]                                                              Lys237, Met253, Leu260,Ala217                            
                                                                                       Arg199, Val184, Phe191, Gly183 
                                                                                       and Pro185  
[1b(a3, b2, c2, d)]                                                             Glu76, Val249, Arg254, Lys237, 
                                                                                       Ile261, Thr263, Phe191, Leu195 
                                                                                       and Arg199 
[1b (a2, b2, c1, d)]                                                            Asp29, Gly259, Arg254, Cys226, 
                                                                                       Arg79, Glu76, Phe52, Met253  
                                                                                       and Val213 
[1b (a3, b2, c1, d)]                                                             Met253, Gln78, Met74 and  
                                                                                       Leu260 
[1b (a4, b2, c3, d)]                                                             Ser28, Phe52, Leu260, Tyr81 and 
                                                                                       Met74 
[1b (a2, b3, c2, d)]                                                             Arg254, Glu75, Cys226, Tyr81  
                                                                                       Phe182, Thr224, Gly259 and  
                                                                                       Gln262 